Have a personal or library account? Click to login
The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome Cover

The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome

Open Access
|Aug 2018

References

  1. 1. Kamceva G, Vavlukis M, Kitanoski D, Kedev S. Newly Diagnosed Diabetes and Stress Glycaemia and Its’ Association with Acute Coronary Syndrome. Open Access Maced J Med Sci 2015; 3(4): 607-12.10.3889/oamjms.2015.103487789527275295
  2. 2. AlNemer KA. Important high light on diabetes in acute coronary syndrome cases: Saudi Arabia. Integrative Molecular Medicine 2016; Volume 3(2): 562-3.10.15761/IMM.1000205
  3. 3. Lugg ST, May CJK, Nightingale P, et al. HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice? Journal of Diabetes & Metabolic Disorders 2017; 16: 14.10.1186/s40200-017-0296-4
  4. 4. Tamita K, Katayama M, Takagi T, et al. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations. Heart 2012; 98(11): 848-54.10.1136/heartjnl-2012-301629335185322581733
  5. 5. Lazzeri C, Valente S, Chiostri M, et al. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol. 2014; 6(4): 140-7.10.4330/wjc.v6.i4.140399933424772254
  6. 6. George A, Bhatia RT, Buchanan GL, et al. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study. PLoS ONE 2015; 10(11): e014204510.1371/journal.pone.0142045464662826571120
  7. 7. Krinsley JS, Preiser JC, Hirsch IB. Safety and Efficacy of Personalized Glycemic Control in Critically Ill Patients. A 2-Year Before and After Interventional Trial. Endocr Pract. 2017; 23(3): 318-30.10.4158/EP161532.OR27967228
  8. 8. Angeli F, Verdecchia P, Karthikeyan G, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev. 2010; 6(2): 102-10.10.2174/15733991079090941320034367
  9. 9. Ibanez B, James S, Agewall S, Antunes MJ, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, ehx393, https://doi.org/10.1093/eurheartj/ehx39310.1093/eurheartj/ehx39328886621
  10. 10. Hyperglycemia in acute coronary syndromes: management. NICE Clinical guideline [CG130] Published date: October 2011. https://www.nice.org.uk/guidance/cg130
  11. 11. Wei CH, Litwin SE. Hyperglycemia and Adverse Outcomes in Acute Coronary Syndromes: Is Serum Glucose the Provocateur or Innocent Bystander? Diabetes 2014; 63(7): 2209-12.10.2337/db14-057124962919
  12. 12. Chiang FT, Shyu KG, Wu CJ, et al. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. Journal of the Formosan Medical Association 2014; Vol 113 (11): 794-802.10.1016/j.jfma.2013.08.00124076272
DOI: https://doi.org/10.2478/prilozi-2018-0022 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Language: English
Page range: 37 - 50
Published on: Aug 13, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2018 Marija Vavlukis, Biljana Zafirovska, Emilija Antova, Bekim Pocesta, Enes Shehu, Hajber Taravari, Irena Kotlar, Darko Kitanovski, Danica Petkoska, Ivan Vasilev, Filip Janusevski, Ivica Bojovski, Sashko Kedev, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.